المؤلفون: Glaviano, Antonino, Foo, Aaron, S C, Lam, Hiu, Y, Yap, Kenneth, C H, Jacot, William, Jones, Robert, H, Eng, Huiyan, Nair, Madhumathy, G, Makvandi, Pooyan, Geoerger, Birgit, Kulke, Matthew, H, Baird, Richard, D, Prabhu, Jyothi, S, Carbone, Daniela, Pecoraro, Camilla, Teh, Daniel, B L, Sethi, Gautam, Cavalieri, Vincenzo, Lin, Kevin, H, Javidi-Sharifi, Nathalie, R, Toska, Eneda, Davids, Matthew, S, Brown, Jennifer, R, Diana, Patrizia, Stebbing, Justin, Fruman, David, A, Kumar, Alan, P

المساهمون: Università degli studi di Palermo - University of Palermo, National University of Singapore (NUS), Institut de Recherche en Cancérologie de Montpellier (IRCM - U1194 Inserm - UM), CRLCC Val d'Aurelle - Paul Lamarque-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Montpellier (UM), University of Glasgow, Cardiff University, Istituto Italiano di Tecnologia (IIT), Immunologie des tumeurs et immunothérapie (UMR 1015), Université Paris-Sud - Paris 11 (UP11)-Institut Gustave Roussy (IGR)-Institut National de la Santé et de la Recherche Médicale (INSERM), Boston University Boston (BU), Cancer Research UK Cambridge Institute Cambridge, Royaume-Uni (CRUK), University of Cambridge UK (CAM), Università degli studi di Catania = University of Catania (Unict), Dana-Farber Cancer Institute Boston, Harvard Medical School Boston (HMS), Johns Hopkins Bloomberg School of Public Health Baltimore, Johns Hopkins University (JHU), Imperial College London, University of California (UC)

المصدر: ISSN: 1476-4598 ; Molecular Cancer ; https://hal.science/hal-04583150Test ; Molecular Cancer, 2023, 22 (1), pp.138. ⟨10.1186/s12943-023-01827-6⟩.

مصطلحات موضوعية: AKT inhibitors, ATP-competitive mTOR inhibitors, Allosteric mTOR inhibitors, Bi-steric mTOR inhibitors, Cancer, Dual PI3K/mTOR inhibitors, Isoform-specific PI3K inhibitors, PDK1 inhibitors, PI3K/AKT/mTORC pathway, Pan PI3K inhibitors, MESH: Humans, MESH: Phosphatidylinositol 3-Kinases, MESH: Proto-Oncogene Proteins c-akt, MESH: Signal Transduction, MESH: TOR Serine-Threonine Kinases, MESH: Neoplasms, [SDV.CAN]Life Sciences [q-bio]/Cancer, [SDV.BBM.GTP]Life Sciences [q-bio]/Biochemistry, Molecular Biology/Genomics [q-bio.GN], [SDV.SP.PHARMA]Life Sciences [q-bio]/Pharmaceutical sciences/Pharmacology

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/37596643; hal-04583150; https://hal.science/hal-04583150Test; https://hal.science/hal-04583150/documentTest; https://hal.science/hal-04583150/file/12943_2023_Article_1827.pdfTest; PUBMED: 37596643; PUBMEDCENTRAL: PMC10436543

الإتاحة: https://doi.org/10.1186/s12943-023-01827-6Test
https://hal.science/hal-04583150Test
https://hal.science/hal-04583150/documentTest
https://hal.science/hal-04583150/file/12943_2023_Article_1827.pdfTest

المؤلفون: Olivier Tredan, Cecile Vicier, Thibault Dayris, Olivia Fromigué, Ibrahim Bouakka, Bojana Stefanovska, Véronique Scott, Anna Rocca, Olivia Le Saux, Fabrice Andre, Suzette Delaloge, Thomas Bachelot, Vasily Ogryzko

المساهمون: Prédicteurs moléculaires et nouvelles cibles en oncologie (PMNCO), Institut Gustave Roussy (IGR)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Paris-Saclay, Institut Gustave Roussy (IGR), Aspects métaboliques et systémiques de l'oncogénèse pour de nouvelles approches thérapeutiques (METSY), Institut Gustave Roussy (IGR)-Université Paris-Saclay-Centre National de la Recherche Scientifique (CNRS), Département de médecine oncologique [Gustave Roussy], Centre National de la Recherche Scientifique (CNRS), Département d'Oncologie Médicale [Lyon] ( Centre Léon Bérard), Centre Léon Bérard [Lyon], FROMIGUE, OLIVIA

المصدر: Cancer Research
Cancer Research, American Association for Cancer Research, 2020, 80 (11), pp.2190-2203. ⟨10.1158/0008-5472.CAN-19-2366⟩
Cancer Research, 2020, 80 (11), pp.2190-2203. ⟨10.1158/0008-5472.CAN-19-2366⟩

مصطلحات موضوعية: Cancer Research, Spliceosome, mTOR inhibitors, RNA splicing, Gustave Roussy (taxe d'apprentissage), Down-Regulation, Gene Expression, Antineoplastic Agents, Cell Cycle Proteins, [SDV.CAN]Life Sciences [q-bio]/Cancer, Protein Serine-Threonine Kinases, Biology, 03 medical and health sciences, 0302 clinical medicine, Opération Parrains Chercheurs, Downregulation and upregulation, [SDV.CAN] Life Sciences [q-bio]/Cancer, Cell Line, Tumor, Neoplasms, Odyssea, Dassault Foundation, medicine, Humans, Everolimus, Breast, Promoter Regions, Genetic, Psychological repression, PI3K/AKT/mTOR pathway, 030304 developmental biology, mammalian target of rapamycin, Sirolimus, 0303 health sciences, Kinase, TOR Serine-Threonine Kinases, FKBP Financial support: This work was supported by INSERM, RNA-Binding Proteins, Cancer, medicine.disease, 3. Good health, Repressor Proteins, Oncology, TRIB3, 030220 oncology & carcinogenesis, MCF-7 Cells, Cancer research, Rapalogs regulate pre-mRNA splicing TRB3

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cf0c777d140ecb278ed542caff1cb62fTest
https://www.hal.inserm.fr/inserm-02768801/file/2190.full.pdfTest